查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726122

美國生物分析測試服務市場規模、佔有率、趨勢分析報告：按分子、測試、工作流程、最終用途和細分市場預測，2025-2030 年

U.S. Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small Molecule, Large Molecule), By Test, By Workflow, By End-use (Pharma & BioPharma Companies, CDMO, CRO), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年美國生物分析測試服務市場規模將達到 19.8 億美元，2025 年至 2030 年的複合年成長率將達到 9.33%。

美國生物分析測試服務產業的成長受到多種因素的推動，例如藥物開發和核准流程的增加、對生技藥品、生物相似藥和基因治療的需求不斷成長以及測試服務外包的增加。此外，嚴格的 FDA 法規也推動了對嚴格生物分析測試的需求。此外，生物分析測試設施的擴建也是推動市場成長的關鍵方面。

一些工業和生物製藥公司正在大力投資升級和擴展其測試基礎設施，以滿足對先進生物分析服務日益成長的需求。此外，複雜生技藥品、生物相似藥、基因療法和個人化醫療發展的激增推動了對先進測試平台的需求，以執行複雜的生物分析，如藥物動力學、生物標記發現和免疫抗原性評估。

此外，一些服務供應商已經開發出整合高解析度質譜 (HRMS)、NGS 和自動化技術的最先進的設施，以提供更快、更準確、更具成本效益的生物分析測試，進一步促進發展。例如，2024年9月，美國實驗室控股公司宣布完成其位於待開發區的實驗室的擴建。此次擴展旨在支持罕見疾病、腫瘤學和其他治療領域的先進療法（包括細胞和基因療法）的臨床前和臨床分子分析檢測服務的開發和檢驗。此次擴張為公司帶來了競爭優勢。

加強監管控制和對生物分析測試重要性的認知是推動生物分析測試服務市場成長的主要因素。隨著美國FDA 和 EMA 等多個監管機構推出嚴格的藥物開發指南，特別是在藥物動力學、動態和生物等效性測試方面，外包趨勢日益成長。這些指南強調需要準確可靠的生物分析方法來提高新藥和生物相似藥的安全性和有效性。例如，美國FDA的生物分析方法驗證指南為方法開發、驗證和樣品分析提供了明確的標準，並推動製藥公司尋求合約服務供應商的專業知識。此外，市場參與企業透過提供先進的分析平台和標準化通訊協定來幫助發起人遵守監管要求，從而推動市場需求。

同樣，技術進步和不斷成長的研發投入也是推動美國生物分析測試服務產業成長的關鍵因素。高性能組織篩檢(HTS)、液相層析法-質譜 (LC-MS) 和次世代定序 (NGS) 等創新技術的不斷發展，顯著提高了生物分析測試的準確性、速度和靈敏度。這些技術創新正在幫助服務供應商執行更複雜的測試，並獲得有關藥物療效、安全性、藥物動力學等的準確數據。此外，自動化和人工智慧 (AI) 融入生物分析工作流程簡化了流程、減少了人為錯誤並提高了吞吐量。預計這些因素將在預計的時間內推動市場發展。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國生物分析測試服務市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 投資金籌措視角
  • 臨床試驗量分析（2024年）
    • 各地區臨床試驗總數（2024年）
    • 各階段臨床試驗總數（2024 年）
    • 依研究設計分類的臨床試驗總數（2024 年）
    • 按主要治療領域分類的臨床試驗總數（2024年）
  • 定價模式分析
  • 科技
  • 法律規範
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章美國生物分析測試服務市場：分子、估計和趨勢分析

  • 美國生物分析測試服務市場（按分子）：細分儀表板
  • 美國生物分析測試服務市場（按分子）：變異分析
  • 依分子分類，2018-2030
  • 小分子
  • 高分子
    • 液相層析質譜研究
    • 免疫檢測
    • 其他大分子檢測

第5章美國生物分析測試服務市場：測試、估計和趨勢分析

  • 美國生物分析測試服務市場（按測試）：細分儀表板
  • 美國生物分析測試服務市場（按測試）：變異分析
  • 2018-2030 年測試
  • ADME
    • 體內
    • 體外
  • 藥物動力學（PK）
  • 動態（PD）
  • 生物有效性
  • 生物等效性
  • 生物標記檢測
  • 基於細胞的檢測
  • 病毒檢測
  • 其他

第6章美國生物分析測試服務市場：工作流程、估計和趨勢分析

  • 美國生物分析測試服務市場（按工作流程）：細分儀表板
  • 美國生物分析測試服務市場（按工作流程）：變異分析
  • 按工作流程，2018-2030
  • 樣品採集和製備
    • 樣本的採集、處理和儲存
    • 蛋白質沉澱
    • 液-液萃取
    • 固相萃取
    • 其他
  • 方法開發和檢驗
  • 樣品分析
    • 連字符技術
    • 層析法技術
    • 電泳
    • 配體結合試驗
    • 質譜法
    • 光譜技術
    • 基因組和分子技術
  • 其他

第7章美國生物分析測試服務市場最終用途、預測與趨勢分析

  • 美國生物分析測試服務市場（按最終用途）：細分儀表板
  • 美國生物分析測試服務市場（依最終用途）：變異分析
  • 按應用，2018-2030 年
  • 製藥和生物製藥公司
  • CDMO
  • 執行長（CRO）
  • 其他

第8章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • ICON plc
    • Charles River Laboratories International, Inc.
    • Laboratory Corporation of America Holdings.
    • IQVIA Inc.
    • Syneos Health
    • SGS SA
    • Intertek Group Plc
    • Pace Analytical Services, LLC
    • Medpace Holdings, Inc.
    • North America Science Associates Inc.（NAMSA）
Product Code: GVR-4-68040-292-0

Market Size & Trends:

The U.S. bioanalytical testing services market size was estimated at USD 1.98 billion in 2024 and is expected to grow at a CAGR of 9.33% from 2025 to 2030. The growth of the U.S. bioanalytical testing services industry is driven by several factors, such as the rising drug development and approval process, growing demand for biologics, biosimilars, and gene therapies, and rising outsourcing of testing services. In addition, Stringent FDA regulations are driving the need for precise bioanalytical testing. Furthermore, the expansion of bioanalytical testing facilities is another key aspect driving the market growth.

Several industry players and biopharmaceutical companies are investing significantly to upgrade and expand their testing infrastructure to meet the growing demand for advanced bioanalytical services. Moreover, a surge in the number of complex biologics, biosimilars, gene therapies, and personalized medicine development is further creating the need for sophisticated testing platforms to perform complex bioanalyses, such as pharmacokinetics, biomarker discovery, and immunogenicity assessments.

Moreover, several service providers are developing state-of-the-art facilities integrated with high-resolution mass spectrometry (HRMS), NGS, and automation technologies to offer faster, more accurate, and cost-effective bioanalytical testing, further propelling market progression. For instance, in September 2024, Laboratory Corporation of America Holdings announced the completion expansion of its laboratory in Greenfield. The expansion aimed to o support the development and validation of preclinical and clinical molecular bioanalytical testing services for advanced therapies, including cell and gene therapies for rare diseases, oncology, and other therapeutic areas. This expansion offered a competitive advantage to the firm.

Increasing regulatory control and awareness regarding the importance of bioanalytical testing are key factors propelling the growth of the bioanalytical testing service market. The introduction of stringent guidelines on drug development, particularly in pharmacokinetics, pharmacodynamics, and bioequivalence testing by several regulatory agencies, such as the U.S. FDA and EMA, leads to a rising preference for outsourcing. These guidelines highlight the need for precise and reliable bioanalytical methods to enhance the safety and efficacy of new drugs & biosimilars. For instance, the U.S. FDA's Bioanalytical Method Validation Guidance provides clear standards for method development, validation, and sample analysis, which have driven pharmaceutical companies to seek specialized expertise from contract service providers. Moreover, the market participants assist sponsors in complying with regulatory requirements by offering advanced analytical platforms and standardized protocols, driving market demand.

Likewise, technological advancements and growing R&D investments are key factors driving the U.S. bioanalytical testing service industry growth. The continuous developments of innovative technologies, such as High-Throughput Screening (HTS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Next-generation Sequencing (NGS), have significantly enhanced the precision, speed, and sensitivity of bioanalytical testing. These innovations assist service providers in conducting more complex studies and gaining accurate data on drug efficacy, safety, and pharmacokinetics, among others. Moreover, integrating automation and Artificial Intelligence (AI) into bioanalytical workflows streamlined processes, reduced human error, and improved throughput. Such factors are anticipated to drive the market over the estimated period.

U.S. Bioanalytical Testing Services Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. bioanalytical testing services market report based on molecule, test, workflow, and end-use:

  • Molecule Outlook (Revenue, USD Million, 2018 - 2030)
  • Small Molecule
  • Large Molecule
    • LC-MS Studies
    • Immunoassays
    • Pharmacokinetics (PK)
    • ADA Assay
    • Other immunoassays
    • Other Large Molecule Tests
  • Test Outlook (Revenue, USD Million, 2018 - 2030)
  • ADME
    • In-vivo
    • In-vitro
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Bioavailability
  • Bioequivalence
  • Biomarker Testing
  • Cell-based Assay
  • Virology Testing
  • Other Tests
  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Sample Collection and Preparation
    • Sample Collection, Handling and Storage
    • Protein Precipitation
    • Liquid-Liquid Extraction
    • Solid Phase Extraction
    • Others
  • Method Development and Validation
  • Sample Analysis
    • Hyphenated Technique
    • Chromatographic Technique
    • Electrophoresis
    • Ligand Binding Assay
    • Mass Spectrometry
    • Spectroscopic Techniques
    • Nuclear Magnetic Resonance (NMR)
    • Others
    • Genomic and Molecular Techniques
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing (NGS)
    • Others
  • Other Processes
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharma & BioPharma Companies
  • CDMO
  • CRO
  • Others

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Molecule
    • 1.2.2. Test
    • 1.2.3. Workflow
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements & Growing R&D Investments
      • 3.2.1.2. Regulatory Control and Increasing Awareness Regarding Bioanalytical Testing
      • 3.2.1.3. Expansion of Bioanalytical Testing Facilities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance Issues While Outsourcing
      • 3.2.2.2. Data Security Concerns
  • 3.3. Investments & Funding Perspective
  • 3.4. Clinical Trials Volume Analysis, (2024)
    • 3.4.1. Total Number Of Clinical Trials By Region (2024)
    • 3.4.2. Total Number Of Clinical Trials, By Phase (2024)
    • 3.4.3. Total Number Of Clinical Trials, By Study Design (2024)
    • 3.4.4. Total Number Of Clinical Trials, By Key Therapeutic Area (2024)
  • 3.5. Pricing Model Analysis
  • 3.6. Technology Landscape
  • 3.7. Regulatory Framework
  • 3.8. Market Analysis Tools
    • 3.8.1. Porter's Five Force Analysis
    • 3.8.2. PESTEL by SWOT Analysis
    • 3.8.3. COVID-19 Impact Analysis

Chapter 4. U.S. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis

  • 4.1. U.S. Bioanalytical Testing Services Market, By Molecule: Segment Dashboard
  • 4.2. U.S. Bioanalytical Testing Services Market, By Molecule: Movement Analysis
  • 4.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Molecule, 2018 - 2030 (USD Million)
  • 4.4. Small Molecule
    • 4.4.1. Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Large Molecule
    • 4.5.1. Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. LC-MS Studies
      • 4.5.2.1. LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Immunoassays
      • 4.5.3.1. Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.2. Pharmacokinetics (PK)
        • 4.5.3.2.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.3. ADA Assay
        • 4.5.3.3.1. ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.4. Other
        • 4.5.3.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Large Molecule Tests
      • 4.5.4.1. Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis

  • 5.1. U.S. Bioanalytical Testing Services Market, By Test: Segment Dashboard
  • 5.2. U.S. Bioanalytical Testing Services Market, By Test: Movement Analysis
  • 5.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Test, 2018 - 2030 (USD Million)
  • 5.4. ADME
    • 5.4.1. ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. In-vivo
      • 5.4.2.1. In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. In-vitro
      • 5.4.3.1. In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pharmacokinetics (PK)
    • 5.5.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Pharmacodynamics (PD)
    • 5.6.1. Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Bioavailability
    • 5.7.1. Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Bioequivalence
    • 5.8.1. Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Biomarker Testing
    • 5.9.1. Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Cell-based Assay
    • 5.10.1. Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Virology Testing
    • 5.11.1. Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Other Tests
    • 5.12.1. Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis

  • 6.1. U.S. Bioanalytical Testing Services Market, By Workflow: Segment Dashboard
  • 6.2. U.S. Bioanalytical Testing Services Market, By Workflow Movement Analysis
  • 6.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
  • 6.4. Sample Collection and Preparation
    • 6.4.1. Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Sample Collection, Handling and Storage
      • 6.4.2.1. Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Protein Precipitation
      • 6.4.3.1. Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Liquid-Liquid Extraction
      • 6.4.4.1. Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Solid Phase Extraction
      • 6.4.5.1. Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Method Development and Validation
    • 6.5.1. Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Sample Analysis
    • 6.6.1. Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Hyphenated Technique
      • 6.6.2.1. Hyphenated Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Chromatographic technique
      • 6.6.3.1. Chromatographic Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Electrophoresis
      • 6.6.4.1. Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Ligand Binding Assay
      • 6.6.5.1. Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Mass Spectrometry
      • 6.6.6.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Spectroscopic Techniques
      • 6.6.7.1. Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.2. Nuclear Magnetic Resonance (NMR)
        • 6.6.7.2.1. Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.7.3. Others
        • 6.6.7.3.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Genomic and Molecular Techniques
      • 6.6.8.1. Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.2. Polymerase Chain Reaction (PCR)
        • 6.6.8.2.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.3. Next-Generation Sequencing (NGS)
        • 6.6.8.3.1. Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.8.4. Others
        • 6.6.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Other Processes
    • 6.7.1. Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Bioanalytical Testing Services Market, By End Use: Segment Dashboard
  • 7.2. U.S. Bioanalytical Testing Services Market, By End Use: Movement Analysis
  • 7.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharma & BioPharma Companies
    • 7.4.1. Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. CDMO
    • 7.5.1. CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. CRO
    • 7.6.1. CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. ICON plc
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Charles River Laboratories International, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Laboratory Corporation of America Holdings.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. IQVIA Inc.
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Syneos Health
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. SGS SA
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Intertek Group Plc
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Pace Analytical Services, LLC
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Medpace Holdings, Inc.
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. North America Science Associates Inc. (NAMSA)
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Molecule, 2018 - 2030 (USD Million)
  • Table 3 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Tests, 2018 - 2030 (USD Million)
  • Table 4 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Immunoassay Tests, 2018 - 2030 (USD Million)
  • Table 5 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Test, 2018 - 2030 (USD Million)
  • Table 6 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by ADME Test, 2018 - 2030 (USD Million)
  • Table 7 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 8 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Collection and Preparation, 2018 - 2030 (USD Million)
  • Table 9 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Analysis, 2018 - 2030 (USD Million)
  • Table 10 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Spectroscopic Techniques, 2018 - 2030 (USD Million)
  • Table 11 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Genomic and Molecular Techniques, 2018 - 2030 (USD Million)
  • Table 12 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Financial performance

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. Bioanalytical Testing Services Market dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Bioanalytical Testing Services Market: Molecule Outlook and Key Takeaways
  • Fig. 20 U.S. Bioanalytical Testing Services Market: Molecule Movement Analysis
  • Fig. 21 Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Bioanalytical Testing Services Market: Test Outlook and Key Takeaways
  • Fig. 30 U.S. Bioanalytical Testing Services Market: Test Movement Analysis
  • Fig. 31 ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Bioanalytical Testing Services Market: Workflow Outlook and Key Takeaways
  • Fig. 43 U.S. Bioanalytical Testing Services Market: Workflow Movement Analysis
  • Fig. 44 Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Hyphenated technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Chromatographic technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 U.S. Bioanalytical Testing Services Market: End Use outlook and key takeaways
  • Fig. 66 U.S. Bioanalytical Testing Services Market: End Use movement analysis
  • Fig. 67 Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key company categorization
  • Fig. 72 Service heat map analysis
  • Fig. 73 Strategic framework